Gland Pharma, Zydus Lifesciences, Natco Pharma, Aurobindo Pharma and Sun Pharmaceuticals were among healthcare stocks leading the slide in the pharma pack on Friday after the US President Donald Trump announced 100 per cent tariffs starting October 1. While the tariff primarily targets branded drugs, Choice Broking said there is ambiguity over whether complex generics and specialty medicines might also be affected, which could pose challenges for companies relying on US exports. Advertisement

Trump though clarified pharma firms with manufacturing plants under construction in the US will be exempt, offering an opportunity to mitigate tariff exposure," it said.

Gland Pharma dropped 4.03 per cent to open at Rs 1,892.50. Zydus Life fell 3.54 per cent to open at Rs 990.55. Natco Pharma slip

See Full Page